Podcasts about ectrims

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, Veronique Miron, PhD, The John David Eaton Chair in Multiple Sclerosis at the University of Toronto, gave a clinical overview of the 2025 ACTRIMS Forum, which is held February 27-March 1, in West Palm Beach, Florida. Miron, an expert in the field, spoke on the reasons behind this year's theme of "Making Connections," as well as some of the most notable and innovative sessions attending clinicians should keep their eyes on. Additionally, she spoke on how the curriculum at this year's meeting aligns with the most recent MS McDonald Diagnostic Criteria that was presented at ECTRIMS 2024. Miron also spoke on the different seminars that cover drug development, innovative new treatment approaches, and Bruton Tyrosine Kinase (BTK) inhibitors. Furthermore, she provided commentary on how this year's meeting differs from previous iterations of ACTRIMS, highlighting some of the changes to the agenda and the advances in MS research. Looking for more multiple sclerosis discussion? Check out the NeurologyLive® Multiple sclerosis clinical focus page. Episode Breakdown: 1:10 – Reasons behind "Making Connections" theme  2:50 – Overviewing key unique sessions and forums from the meeting 5:10 – Aligning curriculum with 2024 MS McDonald Criteria 7:00 – Neurology News Minute 9:00 – Drug development topics from ACTRIMS 2025 12:20 – Differences between ACTRIMS 2025 vs ACTRIMS 2024 The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Axsome Therapeutics' AXS-07 for Migraine Treatment FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

When we talk about myelin damage, most of us typically think of the brain. After all, that myelin is located in your central nervous system. But the inflammation that causes myelin damage may be triggered by activity that's taking place well south of your central nervous system, in your gut microbiome, the colony of trillions of bacteria and microorganisms that live in your intestines.  Dr. Ashutosh Mangalam joins me to help us understand what this gut-brain connection is all about, how that connection impacts MS, and what you can do to change the makeup of your gut microbiome. Dr. Mangalam is an Associate Professor of Pathology at the Carver College of Medicine at the University of Iowa, where his research is focused on studying the gut microbiome and the immune system in multiple sclerosis. We're also talking about the newly published guidance from the European Committee for Treatment and Research in MS and the European Society for Blood and Marrow Transplantation, recommending autologous hematopoietic stem cell transplantation (aHSCT) for treating some cases of relapsing-remitting MS. We'll tell you about an experimental drug that may resolve MS-related vision issues through remyelination.  And we'll introduce you to this year's winner of the Barancik Prize for Innovation in MS Research. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: The gut-brain connection (and what it means if you're liviing with MS)  :22 The European Committee for Treatment and Research in MS and the European Society for Blood and Marrow Transplantation issue a recommendation for stem cell therapy to treat relapsing-remitting MS  1:35 Researchers develop a drug that may resolve MS-related vision issues through remyelination  4:44 National MS Society names this year's winner of the Barancik Prize for Innovation in MS Research  7:23 Dr. Ashutosh Mangalam explains how (and why) the brain-gut connection impacts MS    11:14 Share this episode  35:38 Have you downloaded the free RealTalk MS app?  35:58 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/388 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS on YouTube https://www.youtube.com/@RealTalkMS Autologous Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder -- Recommendations from ECTRIMS and EBMT https://www.nature.com/articles/s41582-024-01050-x National MS Society Releases Recommendations for aHSCT-Bone Marrow Transplant for MS https://nationalmssociety.org/news-and-magazine/news/national-ms-society-releases-recommendations STUDY: Incomplete Remyelination Via Therapeutically Enhanced Oligodendrogenesis Is Sufficient to Recover Visual Cortical Functionhttps://www.nature.com/articles/s41467-025-56092-6 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 388 Guest: Dr. Ashutosh Mangalam Privacy Policy

One of the most important MS research events every year is the annual European Committee for Treatment and Research in MS Scientific Congress, usually referred to by its acronym, ECTRIMS.    You've made our podcast episode that followed ECTRIMS the most downloaded episode of the year. So, this week, I'm revisiting the two conversations that I had immediately after the ECTRIMS conference ended. In what has become an annual tradition, it's my privilege to sit down with the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, just minutes after the conclusion of ECTRIMS to get his first impressions of the news and presentations that caught his eye.   This year, I also wanted to bring you the perspective of someone who's living with MS, who attended ECTRIMS for the very first time.  So, less than an hour after the conference concluded, I had a conversation with Kristine Werner Ozug. (Full disclosure, Kristine is a member of the RealTalk MS team.) We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Revisiting ECTRIMS 2024   :22 Dr. Bruce Bebo shares the announcements and presentations that caught his eye at ECTRIMS  1:59 Kristine Werner Ozug shares a patient's perspective on attending the largest MS research conference in the world  14:07 Share this episode  26:54 Have you downloaded the free RealTalk MS app?  27:14 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/383 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS at ECTRIMS on YouTube https://www.youtube.com/playlist?list=PLATxgj1uHpxPOTklQKDkASWTEBoHXVGH1 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 383 Guests: Dr. Bruce Bebo and Kristine Werner Ozug Privacy Policy

The holiday season provides me with an opportunity to indulge in what's become a RealTalk MS tradition. I reserve the last two episodes of the year to revisit the most compelling and important conversations that I've had over the past year. This week, I'm revisiting two conversations I had with two experts on MS and women's health issues. MS affects women almost 3 times more frequently than it affects men, which should make understanding how MS might impact other women's health issues a priority. Unfortunately, that hasn't really been the case. The good news is we're seeing that situation change and you can expect to hear much more about MS and women's health in the coming year.    This brings me to two conversations that I had this past year when I talked with Dr. Rhonda Voskuhl and Dr. Anna Shah.    Dr. Shah is an Associate Professor of Neurology and Associate Clinic Director of Outpatient Neurology at the University of Colorado School of Medicine.   Dr. Voskuhl is the Director of the UCLA Multiple Sclerosis Program, she holds the Jack H. Skirball Chair in MS, and Dr. Voskuhl also serves as Faculty Neurologist of the UCLA Comprehensive Menopause Care Program. We have a lot to talk about! Are you ready for RealTalk MS??! Happy Holidays!  :22 This Week: Revisiting our deep dive into women's health and MS   :44 Dr. Rhonda Voskuhl discusses her research looking at why MS affects men and women differently  2:34 Dr. Anna Shah discusses how MS can affect women's health issues and how those health issues can affect MS  13:30 Share this episode  32:18 Have you downloaded the free RealTalk MS app?  32:38 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/382 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS at ECTRIMS on YouTube https://www.youtube.com/playlist?list=PLATxgj1uHpxPOTklQKDkASWTEBoHXVGH1 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 382 Guests: Dr. Anna Shah, Dr. Rhonda Voskuhl Privacy Policy

Weihnachten ist schön, aber auch eine herausfordernde Phase im Jahr – gerade für Menschen mit Multipler Sklerose. Zwischen Festtagsstimmung, Vorbereitungen und den hohen Erwartungen kann es schnell stressig werden. Doch mit etwas Planung und einer entspannten inneren Haltung lässt sich die Adventszeit genießen. Im 8. MS-Kamingespräch teilen Nadja und ich über unsere besten Tipps, wie die Weihnachtszeit trotz MS besinnlich und freudig sein kann. Von gesunden Alternativen für Rezepte über stressfreie Geschenkverpackungen zeigen wir Dir, wie Du den Zauber der Feiertage bewahren kannst, ohne dabei die eigenen Bedürfnisse aus den Augen zu verlieren. Erfahre, wie du dich auf die Feiertage vorbereitest, mit Stress und Erwartungen umgehst und schwierige Momente meistern kannst. Weihnachten muss nicht perfekt sein – es darf so sein, wie es für dich passt. Lass dich inspirieren und starte entspannt in diese besondere Zeit des Jahres! Auf meinem Blog kannst Du das Gespräch Nachlesen: https://ms-perspektive.de/kamingespraech-xmas-24 Inhaltsverzeichnis 1. Das Festtagsessen – gesund und genussvoll 2. Weihnachtsgeschenke – ohne Stress 3. Medikamente und Physio über die Feiertage 4. Umgang mit Erwartungen und Regeln 5. Weihnachtsfeiern barrierefrei gestalten 6. Geschenkideen: Zeit statt Dinge 7. Umgang mit schwierigen Momenten 8. Silvester ohne Druck Abschlussgedanken Bisherige MS-Kamingespräche Mehr zu Nadja Birkenbach Abschlussgedanken Nele von Horsten: Weihnachten ist, was du daraus machst. Es muss nicht perfekt sein. Genieße die Zeit so, wie es dir guttut, und nimm den Druck raus. Nadja Birkenbach: Genau. Es ist wichtig, dass es euch gut geht, dass ihr auf euch achtet und euch die Zeit so gestaltet, dass sie für euch schön ist – egal, ob das ein traditionelles Weihnachten ist oder ein ganz entspanntes. Nele von Horsten: Frohe Weihnachten euch allen und bis bald! Bisherige MS-Kamingespräche 7. MS-Kamingespräch über den ECTRIMS allgemein und den Patient Day 6. MS-Kamingespräch über kleine Helferlein 5. MS-Kamingespräch über unangenehme Fragen zur MS 4. MS-Kamingespräch zur Arztwahl bei MS 3. MS-Kamingespräch zur Ernährung bei MS 2. MS-Kamingespräch zum Outing im Job und in Beziehungen 1. MS-Kamingespräch zur Reaktion anderer auf die Diagnose Nadja Birkenbach Nele von Horsten     Mehr zu Nadja Birkenbach Wenn Du mehr über Nadja Birkenbach erfahren möchtest, dann empfehle ich Dir die Folge zum Interview mit ihr: #205: MS-Patenprogramm in München. Interview mit der Initiatorin Nadja Birkenbach --- Bis bald und mach das Beste aus Deinem Leben, Nele Mehr Informationen und positive Gedanken erhältst Du in meinem kostenlosen Newsletter. Hier findest Du eine Übersicht zu allen bisherigen Podcastfolgen.

Now that he's had a chance to digest all of the research presented at ECTRIMS, Dr. Bruce Bebo, the National MS Society's Executive Vice President of Research, is back to share the key research presented at the largest MS research conference in the world. This episode of RealTalk MS is the perfect follow-up to my initial conversation with Bruce, which occurred just minutes after ECTRIMS ended. (If you missed our conversation, you may want to check out Episode 369 of RealTalk MS.) We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Part 2 of our coverage of ECTRIMS 2024  :22 Dr. Bruce Bebo shares the key research presented at ECTRIMS  1:06 Share this episode  26:13 Have you downloaded the free RealTalk MS app?  26:31 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/373 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS Episode 369: ECTRIMS 2024 with Kristine Werner Ozug and Dr. Bruce Bebo https://realtalkms.com/369 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 373 Guest: Dr. Bruce Bebo Privacy Policy

Nadja berichtet von ihren Live-Eindrücken vom ECTRIMS und Patient Community Day in m Zwiegespräch mit Nele, die digital teilgenommen hat. Du kannst das Interview auf meinem Blog Nachlesen: https://ms-perspektive.de/ms-kamingespraech-ectrims-2024 Diesmal dreht sich alles um die neuesten Eindrücke und Erkenntnisse von der ECTRIMS-Konferenz 2024, vor allem dem Patient Day. Nadja war live vor Ort in Kopenhagen, während ich die Veranstaltung online mitverfolgt habe. Gemeinsam sprechen wir über einige spannende Paper und Präsentationen, darunter die neuen McDonald's-Kriterien zur MS-Diagnose und interessante Studienergebnisse. Besonders im Fokus steht der Patient Community Day, bei dem sich MS-Patienten aus aller Welt austauschen konnten. Nadja teilt ihre Erlebnisse und berichtet von inspirierenden Begegnungen mit anderen Betroffenen und der Bedeutung von Themen wie Ernährung, Bewegung und Reha für den Alltag mit MS. Wenn du hören möchtest, wie andere MS-Betroffene ihre Diagnose aktiv angehen, dann lies weiter oder höre dir unser Gespräch an. Außerdem erfährst du, warum es so wichtig ist, an Studien teilzunehmen und wie Apps unser Leben mit MS erleichtern können. Inhaltsverzeichnis Einführung und Begrüßung Erste Eindrücke vom ECTRIMS Die neuen McDonald's-Kriterien und wichtige Studien Vergleich zwischen Ländern: Zugang zu MS-Medikamenten Der Patient Community Day: Chancen und Verbesserungspotential Motivation durch andere MS-Patienten Forschung und Fortschritt bei MS: Epstein-Barr-Virus und mehr Die Bedeutung eines umfassenden Therapieansatzes: Ernährung, Sport und mehr Technologische Hilfsmittel: Apps und digitale Gesundheitsdaten Deeskalation von Therapien: Wann ist weniger mehr? Die Rolle von Studien und Real-World-Daten Abschluss und Ausblick Bisherige MS-Kamingespräche Mehr zu Nadja Birkenbach Abschluss und Ausblick Nele von Horsten: In diesem Sinne, liebe Nadja, freue ich mich auf unser nächstes Gespräch. Schaut euch unbedingt das Video mit Nadja und Professor Hemmer an – es lohnt sich! Nadja Birkenbach: Ja, und ich freue mich auf Anregungen von unseren Zuhörern. Bis bald! Bisherige MS-Kamingespräche 6. MS-Kamingespräch über kleine Helferlein 5. MS-Kamingespräch über unangenehme Fragen zur MS 4. MS-Kamingespräch zur Arztwahl bei MS 3. MS-Kamingespräch zur Ernährung bei MS 2. MS-Kamingespräch zum Outing im Job und in Beziehungen 1. MS-Kamingespräch zur Reaktion anderer auf die Diagnose Bis bald und mach das Beste aus Deinem Leben, Nele Mehr Informationen und positive Gedanken erhältst Du in meinem kostenlosen Newsletter. Hier findest Du eine Übersicht zu allen bisherigen Podcastfolgen.

Wann kann man über das Deeskalieren oder gar Absetzen einer hochwirksamen Immuntherapie nachdenken und was gilt es dabei zu beachten? Die schriftliche Version zum Nachlesen gibt es auf meinem Blog: https://ms-perspektive.de/ectrims-deeskalieren Hallo und willkommen zu einer weiteren Zusammenfassung vom ECTRIMS 2024, in der es diesmal um das Deeskalieren und das Absetzen der Therapie geht. Dazu gab es sowohl eine wissenschaftliche Vortragsreihe mit sechs Vorträgen, die von Dr. Melinda Magyari und Prof. Bernhard Hemmer moderiert wurde. Und außerdem noch einzelne Poster. Abgesehen von einer Arbeit über NMOSD und MOGAD beschäftigten sich alle wissenschaftlichen Arbeiten mit Multipler Sklerose. Ich stelle alle Arbeiten und deren teils noch vorläufige Ergebnisse vor. Denn schließlich ist es ein Thema, dass wohl die allermeisten von uns beschäftigt. Kann oder sollte ich irgendwann meine Therapie von hoher Wirksamkeit auf eine niedrigere Umstellen oder sogar ganz stoppen und wann ist das ein sicheres Vorgehen. --- Bis bald und mach das Beste aus Deinem Leben, Nele Mehr Informationen und positive Gedanken erhältst Du in meinem kostenlosen Newsletter. Hier findest Du eine Übersicht zu allen bisherigen Podcastfolgen.

Nurses play a specialised and unique role in the journey of people living with multiple sclerosis (MS). At ECTRIMS 2024, MS nurses showcased their experiences and insights into how to effectively support patients. In this episode, host Brett Drummond of MSTranslate talks with veteran MS nurses K-J Lazarus of Austin Health in Australia and Fiona d'Young of the Auckland Hospital in New Zealand.

The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part II of our Patient Community Day episode, host Brett Drummond of MSTranslate talks to Sumaira Ahmed and Trevis Gleason, who are living with NMOSD and MS, respectively, about their experience attending the event.

With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Jiwon Oh. Dr. Oh is a neurologist, scientist, and the Medical Director of the Barlo Multiple Sclerosis Program at St. Michael's Hospital in Ontario, Canada. Dr. Oh is also the Principal Investigator in Gemini, the Phase 3 clinical trial for Tolebrutinib and relapsing-remitting MS. At ECTRIMS, Dr. Oh shared the outcome of the Gemini clinical trial. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims244 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra Guest: Dr. Jiwon Oh Privacy Policy

The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part 1 of our Patient Community Day episode, Elisabeth Kasilingam, Chief Executive Officer of the European Multiple Sclerosis Platform (EMSP) and Vice President of the European Patients' Forum, talks with host Brett Drummond of MSTranslate about bridging the gap between patients, clinicians, and the scientific community.

Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler talked with Proactive's Stephen Gunnion about the company's significant presence at the 40th ECTRIMS Congress in Copenhagen. Muehler emphasised the importance of this event for Immunic, particularly with vidofludimus calcium, its promising treatment for multiple sclerosis (MS). This year marked a milestone for Immunic as it had its own booth for the first time, garnering substantial attention. Muehler detailed the four posters presented, including data from the Phase 2 CALLIPER trial for progressive MS and the drug's potential effect on neuroprotection and MS fatigue. One key area of focus was the potential impact of vidofludimus calcium on MS fatigue, a symptom that severely affects over half of MS patients. He also highlighted the broader relevance of vidofludimus calcium's antiviral properties and its potential effect on EBV reactivation, a known contributor to fatigue. The enthusiasm for Immunic's ongoing Phase 3 and Phase 2 trials shows the company's commitment to addressing unmet needs in MS treatment. With crucial milestones like the CALLIPER trial readout scheduled for April 2025, Immunic continues to play a significant role in advancing MS research. For more interviews and updates on the latest in biotech and pharmaceuticals, be sure to like this video, subscribe to Proactive's YouTube channel, and turn on notifications for future content. #Immunic #MultipleSclerosis #ECTRIMS2024 #VidofludimusCalcium #MSFatigue #Phase3Trials #Biotech #Neuroprotection #MSResearch #EBV #MSAwareness #CALLIPERtrial #ProgressiveMS #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Peter Calabresi. Dr. Peter Calabresi is the Director of the Division of Neuroimmunology and the Director of the Multiple Sclerosis Center at Johns Hopkins Medicine. He is the principal investigator on several clinical trials and oversees research projects focused on developing new anti-inflammatory and neuroprotective therapies for MS. At ECTRIMS, Dr. Calabresi co-chaired what was probably the most highly anticipated presentation at this year's conference: the unveiling of updated criteria for diagnosing MS. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims243 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra Guest: Dr. Peter Calabresi Privacy Policy

The recent ECTRIMS 2024 in Copenhagen showcased the work of young scientific investigators, including this year's ECTRIMS Fellowship recipients Oscar Ayala from Colombia and Zuhal Abasiyanik from Turkey. Every year, ECTRIMS awards fellowships across various categories to promote knowledge and expertise in the field of multiple sclerosis (MS). Oscar and Zuhal spoke with host Brett Drummond of MSTranslate about the research projects that they will be pursuing and how they believe this opportunity will impact their career. The ECTRIMS Fellowship application period for the 2025 cycle is now open. Apply before the deadline of December 1, 2024 at 23:59 CET.

With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Rachel Horne and Professor Kerstin Hellwig. Professor Kerstin Hellwig is the 2024 recipient of the Rachel Horne Prize for Women's Research in MS. Professor Hellwig was honored at ECTRIMS for her pioneering research into understanding and navigating the safety of approved treatments for women with MS before, during, and after pregnancy.  Professor Hellwig is a senior consultant at St Josef Hospital, Ruhr University, Bochum,  Germany, specializing in MS and neuroimmunology, and is a leading clinician-scientist in the field of MS and family planning. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims242 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra Guests: Rachel Horne, Professor Kerstin Hellwig Privacy Policy

ECTRIMS 2024, the largest MS research conference in the world concluded last week, and in this week's episode, we'll be hearing two slightly different perspectives on which news, announcements, and presentations stood out at this year's meeting.   The ECTRIMS conference can feel almost overwhelming. You find yourself among 9 or 10 thousand other attendees, trying to determine which of the more than 1700 scientific presentations you want to learn more about. It's both a marathon and a sprint that seem to be taking place simultaneously. Kristine Werner Ozug is a member of the RealTalk MS team and a person who lives with MS. This week, Kristine shares her perspective on attending ECTRIMS for the first time.  At the conclusion of ECTRIMS, you can almost hear a collective sigh coming from all the attendees. It feels like you've crossed the finish line, but now the work of sorting and processing all that you've seen, heard, and read over what feels like a non-stop 72-hour blur actually begins. Joining me to share his initial thoughts on the ECTRIMS news that caught his eye is the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: ECTRIMS 2024  :22 It's our 7th anniversary!  1:28 Kristine Werner Ozug shares a patient's perspective on attending the largest MS research conference in the world  3:56 Dr. Bruce Bebo shares the news and announcements that caught his eye at ECTRIMS 17:19 Share this episode  28:59 Have you downloaded the free RealTalk MS app?  29:19 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/369 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 369 Guests: Kristine Werner Ozug, Dr. Bruce Bebo Privacy Policy

With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Fred Lublin. Dr. Fred Lublin is the Director of the Corrine Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai. He participated in the development of the very first disease-modifying therapy that was approved for MS. When we talk about relapsing-remitting MS, secondary-progressive MS, or primary-progressive MS, we're using the clinical course descriptions of MS that were developed and subsequently updated by Dr. Lublin and his colleagues. At ECTRIMS, Dr. Lublin gave a presentation on the need to update the way we think about and talk about multiple sclerosis by, once again,  updating those clinical course descriptors. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims241 ADD YOUR VOICE TO THE CONVERSATI I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra Guest: Dr. Fred Lublin Privacy Policy

Former ECTRIMS President and MS Journal Editor-in-Chief Alan Thompson and host Brett Drummond wrap up the last day of ECTRIMS 2024 with their final thoughts and insights.

Anne Helme, Head of Research at MSIF, and host Brett Drummond discuss the key takeaways unveiled on the second day of ECTRIMS 2024 in Copenhagen, as well as the value of global collaboration.

Personalisierte Behandlungen, genetische Risikofaktoren, geschlechtsspezifische Unterschiede und Vorteile früher, hochwirksamer Therapien. Hier kannst du den kompletten Beitrag nachlesen: https://ms-perspektive.de/ectrims-2024-1 Dieses Jahr kommen auf der ECTRIMS 2024 in Kopenhagen, Dänemark, wieder führende Experten für Multiple Sklerose (MS) aus der ganzen Welt zusammen. Die renommierte Konferenz ist die wichtigste Veranstaltung für Forscher, Ärzte und medizinisches Fachpersonal, die alle auf ein gemeinsames Ziel hinarbeiten: die Verbesserung der Lebensqualität durch bahnbrechende Forschung und Fortschritte bei der Behandlung von MS und verwandten Krankheiten. Die Veranstaltung, zu der rund 9.000 Teilnehmer erwartet werden, verspricht ein reichhaltiges Programm mit inspirierenden Grundsatzreden, spannenden Vorträgen und Posterpräsentationen sowie sorgfältig zusammengestellten wissenschaftlichen und pädagogischen Sitzungen. Darüber hinaus wird es zahlreiche Gelegenheiten zum Networking und zur Kontaktaufnahme mit der internationalen MS-Gemeinschaft geben. Ich habe Dir zu Beginn meiner Berichterstattung über die diesjährige Veranstaltung einige spannende Paper mitgebracht. Von Biomarkern, die bei der Vorhersage des Krankheitsverlaufs helfen, bis hin zu neuen Erkenntnissen über genetische Risikofaktoren und geschlechtsspezifische Unterschiede bei der Behandlung unterstreichen diese Ergebnisse die wachsende Bedeutung einer personalisierten Versorgung bei der Behandlung von MS. Zu den wichtigsten Erkenntnissen gehören die Vorteile frühzeitiger, hochwirksamer Behandlungen für Kinder, mit dem MS-Risiko verbundene, durch die Abstammung bedingte genetische Varianten und die therapeutische Trägheit bei der Behandlung von Frauen mit MS. Diese Studien ebnen den Weg für gezieltere und wirksamere Behandlungsstrategien, die die Ergebnisse für MS-Patienten weltweit verändern könnten. Inhaltsverzeichnis Frühe hochwirksame MS-Behandlung bei Kindern zeigt langfristige Vorteile Neue genetische Entdeckungen ebnen den Weg für personalisierte MS-Behandlungen für verschiedene Bevölkerungsgruppen Bluttests helfen, Fortschreiten von Behinderungen bei MS frühzeitig zu erkennen Ungenutzte Chancen: Warum Frauen mit MS seltener frühzeitig hochwirksame Therapien erhalten Quellen Long-term disability outcomes among children with multiple sclerosis treated with high-efficacy therapy, Sharmin, S. et al. (2024). Presented at ECTRIMS 2024. Mavridi, A., Bompou, M.E., Redmond, A. et al. (2024). Current and Emerging Treatment Options in Pediatric Onset Multiple Sclerosis. Sclerosis; 2(2):88-107. https://doi.org/10.3390/sclerosis2020007 Novel ancestry-specific and putative causal genetic variants for multiple sclerosis identified by an ancestry-informed regression and trans-ethnic fine-mapping analysis, McCauley, J.L., et al. (2024). Presented at ECTRIMS 2024.  Serum neurofilament light chain and glial fibrillary acidic protein levels at disease onset unveil immunologic pathways of disability acquisition in multiple sclerosis, Monreal E., et al. (2024). Presented at ECTRIMS 2024. Meier S., Willemse E.A., Schaedelin S., et al. (2023). Serum Glial Fibrillary Acidic Protein Compared with Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurol., 80(3):287-297. doi:10.1001/jamaneurol.2022.5250 Lublin, F. D., Häring, D. A., Ganjgahi, H., et al. (2022). How patients with multiple sclerosis acquire disability. Brain: A Journal of Neurology, 145(9), 3147-3161. https://doi.org/10.1093/brain/awac016 Is there therapeutic inertia in women with MS? Vukusic, S., et al. (2024). Presented at ECTRIMS 2024.  --- Bis bald und mach das Beste aus Deinem Leben, Nele Mehr Informationen und positive Gedanken erhältst Du in meinem kostenlosen Newsletter. Hier findest Du eine Übersicht zu allen bisherigen Podcastfolgen.

ECTRIMS Vice President Bruno Stankoff highlights the most relevant insights from day one of ECTRIMS 2024 in Copenhagen, and provides a glimpse of what to expect from the ECTRIMS society in the coming year.

Immunic Therapeutics CEO Dr Daniel Vitt joined Steve Darling from Proactive to discuss the company's participation at the European Committee for Treatment and Research on Multiple Sclerosis conference, ECTRIMS, the world's largest event dedicated to multiple sclerosis (MS) research. Dr. Vitt emphasized the significance of this event, where Immunic presented four research posters, including key data on vidofludimus calcium, the company's leading compound for MS treatment. "We have an advanced asset in multiple sclerosis in development," Dr. Vitt shared, underscoring the critical unmet medical needs in the field. He elaborated on important topics such as progression independent of relapse activity, which remains a challenging aspect of MS treatment. Immunic's innovative research focuses on the neuroprotective, inflammatory and anti-viral properties of vidofludimus calcium, which could offer new hope to patients with progressive and relapsing forms of the disease. In addition to showcasing their research, Dr. Vitt highlighted the networking opportunities provided by the conference, allowing Immunic to connect with key industry professionals and collaborators in the MS research community. These interactions are essential to advancing both the company's clinical efforts and its understanding of emerging trends in the field. #proactiveinvestors #immunictherapeutics #DanielVitt #MultipleSclerosis #MSResearch #nasdaq #imux #VidofludimusCalcium #Nurr1Activator #ProgressiveMS #RelapsingMS #Pharma #Biotech #MSDrugDevelopment. #MSResearch #Neuroprotection #ECTRIMS2024 #VidofludimusCalcium #Nurr1 #Neuroinflammation #Biotech #Pharmaceuticals #ClinicalResearch #PIRA #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Listen to Romain Marignier from CHU de Lyon and host Brett Drummond discuss highlights of ECTRIMS' new Pre-Day on NMOSD, MOGAD, and other rare neurological conditions.

Living with the unpredictability of MS sometimes feels like riding a rollercoaster. As you experience the twists and turns of life with MS, you can sometimes feel unmoored from the person you thought you were. You can sense your priorities, motivations, and values shifting. And, in those moments, it becomes easy to lose your sense of purpose.   Clinical assistant professor and rehabilitation psychologist at the University of Michigan, Dr. Evan Smith, joins me to discuss how to identify and reconnect with your core values and live a more purposeful and satisfying life.  We'll also tell you about Creating Order, an art exhibit featuring 12 artists living with MS. (Don't miss our conversation with the co-curators and lead artist in this unique exhibit!)  And we're sharing the details of MS Stand Up, a night of comedy and cocktails at the Gotham Comedy Club. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Greetings from ECTRIMS!  :22 Our 7th anniversary is one week away!  2:00 Coming Up: The importance of staying connected to your core values  2:30 Creating Order art exhibit features 12 artists living with MS  3:35 My conversation with Creating Order co-curators Pam Schoenberg and Ted Meyer, and lead artist, Susan Trachman  4:27 MS Stand Up is happening September 30 at the Gotham Comedy Club    15:24 Dr. Evan Smith discusses how to lead a purposeful life while living with MS  16:54 Share this episode  33:17 Have you downloaded the free RealTalk MS app?  33:38 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/368 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Creating Order exhibit at the DNJ Gallery https://dnjgallery.net MS Stand Up https://msstandup.org Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 368 Guests: Pam Schoenberg, Ted Meyer, Susan Trachman, Dr. Evan Smith Privacy Policy

In this era of highly effective treatments, early intervention for multiple sclerosis can be life changing. However, the wide range of initial symptoms often leads to many people being undiagnosed or misdiagnosed, leaving them without the proper care for years. In this podcast episode, we'll discuss the early signs of MS and the key tests, such as specific MRI and spinal fluid results, that are crucial for a timely and accurate diagnosis. Criteria to diagnose MS continues to evolve to help make a diagnosis more swiftly and correctly. Specific MRI findings in the brain and spinal cord can allow for an immediate diagnosis of MS with the first attack. Brand-new updates highlight the role of the optic nerve and even offer a path to diagnosing MS in people who show no neurological symptoms. With so much at stake, a timely and accurate diagnosis of MS is more important than ever. Barry Singer MD, Director of The MS Center for Innovations in Care, interviews: Xavier Montalban MD PhD, Chair of Neurology, Director of CEMCAT (Multiple Sclerosis Center of Catalonia) at Vall d'Hebron University Hospital, Barcelona, Spain   Léorah Freeman MD PhD, Assistant Professor, Dell Medical School Department of Neurology, UT Health Austin Multiple Sclerosis and Neuroimmunology Center 

The following episode has been produced by the European Academy of Neurology (EAN) in collaboration with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), and has been published on both the EAN and ECTRIMS Podcast channels to ensure our joint communities have access to it. In this episode of eanCast: Weekly Neurology, host Melinda Magyari is joined by ECTRIMS Podcast host Brett Drummond to talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero of the Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain and the Multiple Sclerosis Centre of Catalonia (Cemcat). Read the full article here.

EAN Moderator: Melinda Magyari (Copenhagen, Denmark)Special Moderator: Brett Drummond (Melbourne, Australia)Guest: Susana Otero (Barcelona, Spain)In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Brett Drummond talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero. Find the full article here.

Guest: Mar Tintore, MD At this year's European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, learn about a presentation on the new criteria for diagnosing multiple sclerosis (MS) patients with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d'Hebron in Barcelona, Spain.

Guest: Mar Tintore, MD A special guest will be joining the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting on opening day. To learn more about the impact ECTRIMS has had on multiple sclerosis patients over the last 40 years, tune in with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d'Hebron in Barcelona, Spain.

Guest: Mar Tintore, MD The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting is celebrating its 40th anniversary in Copenhagen, Denmark. 9,000 delegates from all over the world are expected to attend this multiday event, which will include keynote lectures, poster sessions, and selected scientific and educational sessions, as well as plenty of philanthropic and networking opportunities and more. Tune in for a brief overview with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d'Hebron in Barcelona, Spain.

The next major step forward in the management of MS involves finding treatments that can repair damaged myelin. If successful, it would offer the potential to start to reverse some of the symptoms experienced by people living with MS. Bruno Stankoff, a neurologist of the Pitié-Salpêtrière Hospital in Paris and vice president of ECTRIMS, and Gianvito Martino, scientific director of the San Raffaele Scientific Institute in Milan, discuss this important MS research area with host Brett Drummond of MSTranslate.

March 28th is Progressive MS Day, a day that offers an opportunity for people affected by MS, patient advocates, healthcare providers, governments, and industry to share stories online and show their support for people living with progressive forms of MS.  My wife, Jeanne, lived with progressive MS for 23 years, so this day holds a special significance for me. Joining me to talk about what Progressive MS Day is all about is my friend, Kevin Reid. Kevin was diagnosed with MS in 2002 and, for the past 10 years, he's been on a mission to crush MS. As MS Awareness Month draws to a close, we're sharing a series of short videos featuring conversations I had with MS experts at the ECTRIMS congress. What makes this video series unique is that iConquer MS invited people living with MS to watch these videos. Then, I interviewed them to get their perspective on the topics the experts were discussing. It's the first time you'll not only hear from the experts, but you'll also get the thoughts and reactions of people who are living with MS. We'll tell you about the neurostimulator that was just designated as a Breakthrough Device for promoting myelin repair. We'll share the details of a newly announced Phase 2 clinical trial for a T-cell therapy for MS. You'll hear about the study that identified a biomarker that reliably predicted the likelihood of future disease activity in people with MS. And we'll tell you where you can catch the video replay of the 2024 ACTRIMS Forum Patient-Centered Webinars. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: March 28th is Progressive MS Day  :22 Have you seen the series of short videos featuring my conversations with MS experts at ECTRIMS along with the thoughts and reactions from people living with MS?  1:00 Catch the video replay of the 2024 ACTRIMS Forum Patient-Centered Webinars  1:57 FDA designates neurostimulator as a breakthrough device for promoting myelin repair in people living with relapsing-remitting MS  2:46 Biotech company PolTREG announces Phase 2 clinical trials to test their Tregs treatment for MS  5:28 Study shows neurofilament light chain levels can reliably predict future disease activity  7:10 Kevin Reid discusses the importance of Progressive MS Day and gives us a preview of CRUSH MS  10:35 Share this episode  28:09 Have you downloaded the free RealTalk MS app?  28:29 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/343 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com VIDEO: Dr. Jiwon Oh shares encouraging results from an extension study of Tolebrutinib, an investigational disease-modifying therapy. Then, two people living with MS share their thoughts about clinical trials and a precision medicine approach to treating MS https://youtu.be/eWoZLF4bZmo VIDEO: Dr. Anthony Feinstein discusses the outcome of the CogEx study, Then, two people living with MS share their thoughts about the impact of this study https://www.youtube.com/watch?v=UtGtCnNkYOY VIDEO: Dr. Annette Langer-Gould discusses the impact of other health conditions on people living with MS. Then, two people living with MS share their thoughts and experiences of  managing their MS along with additional health conditions https://www.youtube.com/watch?v=J83jlqMbsZo VIDEO: Dr. Daniel Ontaneda discusses how artificial intelligence will impact MS treatment. Then, two people living with MS share their thoughts on the potential impact of AI on MS treatment and the future patient experience https://www.youtube.com/watch?v=_fRLW69Xc1A VIDEO: Dr. Robert Motl discusses the benefits of exercise for people living with MS. Then, two people living with MS share their thoughts on how exercise has impacted their MS journey https://www.youtube.com/watch?v=oZDdp8JumFg VIDEO: ACTRIMS Forum 2024 Webcast Replays https://actrims.memberclicks.net/forum-patient-centered-webinars STUDY: Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients with Relapsing Remitting Multiple Sclerosis: Results from the Phase 3 ASCLEPIOS I and II Trials https://pubmed.ncbi.nlm.nih.gov/35432382 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 343 Guest: Kevin Reid Privacy Policy

We often discuss the results of MS research studies on this podcast. In order to get to those results, people living with MS have to step up and volunteer to participate. This week, you'll meet Chiquita Shepard-Knight and Earl Sneed, two participants in the TEAAMS study. Chiquita and Earl will discuss how they discovered the TEAAMS study, what motivated them to get involved, what their experience as study participants was like, and what the results of the study were for them. We'll also take you to Capitol Hill as we share conversations that we had during Hill Day at the National MS Society's Public Policy Conference.  It's MS Awareness Month, and we're sharing new videos that feature interviews with leading MS experts along with the thoughts and reactions of people living with MS. And we'll tell you where you can catch the video replay of the International Progressive MS Alliance's webcast on emerging treatments for progressive MS. We have a lot to talk about! Are you ready for RealTalk MS??! Tomorrow! The ACTRIMS Post-Forum Patient-Centered Webinar  :22 This Week: The patient perspective on participating in an MS research study  1:38 Live! From the Natinal MS Society's Public Policy Conference  2:28 People with MS weign in on the impact of several ECTRIMS presentations  10:17 Catch the video replay of the International Progressive MS Alliance webcast  11:35 Chiquita Shepard-Knight and Earl Sneed discuss their experience participating in the TEAAMS study   12:11 Share this episode  27:18 Have you downloaded the free RealTalk MS app?  27:38 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/342 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com REGISTER: ACTRIMS Post-Forum Patient-Centered Webinar https://fs2.formsite.com/1FItkk/tgx8tu3xg0/index VIDEO: Dr. Jiwon Oh shares encouraging results from an extension study of Tolebrutinib, an investigational disease-modifying therapy. Then, two people living with MS share their thoughts about clinical trials and a precision medicine approach to treating MS https://youtu.be/eWoZLF4bZmo VIDEO: Dr. Anthony Feinstein discusses the outcome of the CogEx study, Then, two people living with MS share their thoughts about the impact of this study https://www.youtube.com/watch?v=UtGtCnNkYOY VIDEO: Dr. Annette Langer-Gould discusses the impact of other health conditions on people living with MS. Then, two people living with MS share their thoughts and experiences of  managing their MS along with additional health conditions https://www.youtube.com/watch?v=J83jlqMbsZo VIDEO: Dr. Daniel Ontaneda discusses how artificial intelligence will impact MS treatment. Then, two people living with MS share their thoughts on the potential impact of AI on MS treatment and the future patient experience https://www.youtube.com/watch?v=_fRLW69Xc1A VIDEO: Dr. Robert Motl discusses the benefits of exercise for people living with MS. Then, two people living with MS share their thoughts on how exercise has impacted their MS journey https://www.youtube.com/watch?v=oZDdp8JumFg VIDEO: International Progressive MS Alliance Webcast Replay: Emerging Treatments for Progressive MS https://www.youtube.com/watch?v=W4hxtl38MBQ The TEAAMS Study https://projectteaams.ahs.uic.edu Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 342 Guests: Chiquita Shepard-Knight and Earl Sneed Privacy Policy

Welcome to Living Well with MS, where we are thrilled to bring you our 150th episode! Donations make our podcasts possible – so we'd like to take the opportunity of this milestone to ask if you could support us. As we mark this significant milestone, we are pleased to welcome Overcoming MS CEO, Alex Holden as our guest. Alex joined Overcoming MS in March 2023 and, during her time at the Charity, has completed a lot! In this episode, she talks to Geoff about meeting the Overcoming MS community, her experience at the ECTRIMS conference (the world's largest research meeting in multiple sclerosis) and the exciting plans for the Overcoming MS charity! Watch this episode on YouTube here. Keep reading for the key episode takeaways. Topics and Timestamps: 01:17 Learn about Alex's background, expertise and how she became CEO of Overcoming MS. 03:30 Alex's view of the most compelling pillars of the Overcoming MS Program and changing your lifestyle based on evidence. 04:46 The mental and physical benefits of wild swimming. 05:56 Meeting the resilient and hopeful Overcoming MS community. 07:58 Abseil off the ArcelorMittal Orbit and other ways to support Overcoming MS. 10:22 How she keeps busy with her teenagers outside of work. 11:23 In-person Overcoming MS events taking place in 2024 you might like to attend. 14:15 Join the Live Well Hub – the Overcoming MS app – where over 2,000 community members are already sharing tips and advice. 17:43 Alex's experience at the largest MS research conference in the world, the 2023 ECTRIMS conference (European and American Committees for Treatment and Research in Multiple Sclerosis). 21:06 Future plans for the Overcoming MS charity. Selected Key Takeaways: Put respect for individuals at the forefront. 02:32 “Everybody needs respect, no matter what struggles they have, no matter what they've gone through. Understanding people's situations are so individual to them, I think that's shaped where I've gone with the rest of my career.” Your diet can contribute to your well-being and energy. 03:42 “I've always been very interested in nutrition. At one point I did consider training as a nutritional therapist. So that's something that I'm really passionate about the importance of diet and how that contributes to your wellbeing rather than taking things out of your diet, how you look at what's contributing to energy.” One of the main reasons Alex was drawn to Overcoming MS was because of the community 06:42 "It is such a strong community and a very giving community. People who have had really quite devastating news are managing to give each other so many levels of support, tips, positivity and hope. To be part of that community and amongst those people who have that mindset, I feel very fortunate. As an organisation, we're really small. We are absolutely dependent on people who are in our Circles, our Ambassadors, and people fundraising for us. There are only twelve staff members, and most of us are part-time; the only way we can support a global community is through the community themselves.” Want to learn more about living a full and happy life with multiple sclerosis? Sign up to our newsletter to hear our latest tips. More info and links: Connect with others following Overcoming MS on the Live Well Hub Fundraise for Overcoming MS Meditate with Overcoming MS facilitator Phil Startin and others Watch the ECTRIMS conference highlights webinar with Brett Drummond Learn more about the Neuroepidemiology Unit at the University of Melbourne New to Overcoming MS? Visit our introductory page  Visit the Overcoming MS website Read more about Alex Follow us on social media: Facebook Instagram YouTube Pinterest Don't miss out:  Subscribe to this podcast and never miss an episode. Listen to our archive of Living Well with MS episodes here. If you like Living Well with MS, please leave a 5-star review. Feel free to share your comments and suggestions for future guests and episode topics by emailing podcast@overcomingms.org. Make sure you sign up to our newsletter to hear our latest tips and news about living a full and happy life with MS. Support us:  If you enjoy this podcast and want to support the ongoing work of Overcoming MS, we would really appreciate it if you could leave a donation here. Every donation, however small, helps us to share the podcast with more people on how to live well with MS.

Klinisch Relevant ist Dein Wissenspartner für das Gesundheitswesen. Drei mal pro Woche, nämlich dienstags, donnerstags und samstags, versorgen wir Dich mit unserem Podcast und liefern Dir Fachwissen für Deine klinische Praxis. Weitere Infos findest Du unter https://klinisch-relevant.de

With more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Robert Motl.  Dr. Motl is a professor in the department of Kinesiology and Nutrition, and a professor in the department of Rehabilitation Sciences at the University of Illinois Chicago. Dr. Motl is responsible for generating much of the foundational research validating the benefits of common physical activity in people living with MS. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims2305 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra with Dr. Robert Motl Guest: Dr. Robert Motl Privacy Policy

With more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Daniel Ontaneda.  Dr. Ontaneda is a neurologist at the Cleveland Clinic Neurological Institute's Mellen Center for Multiple Sclerosis and, while attending the ECTRIMS-ACTRIMS meeting, Dr. Ontaneda co-chaired a scientific session on artificial intelligence in MS. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims2304 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra with Dr. Daniel Ontaneda Guest: Dr. Daniel Ontaneda Privacy Policy

With more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Annette Langer-Gould.  Dr. Langer-Gould is an MS Specialist at Kaiser-Permanente, and while at the ECTRIMS-ACTRIMS meeting, she co-chaired a session on MS and comorbidities. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims2303 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra with Dr. Annette Langer-Gould Guest: Dr. Annette Langer-Gould Privacy Policy

With more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Anthony Feinstein.  Dr. Feinstein is a Professor of Psychiatry at the University of Toronto, and his expertise is in the neuropsychiatry of multiple sclerosis. Dr. Feinstein has studied behavioral disorders in people living with MS for 26 years. He also maintains a busy clinical practice in which over 80% of the patients are people living with MS. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims2302 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS Extra with Dr. Anthony Feinstein Guest: Dr. Anthony Feinstein Privacy Policy

This week, we're sharing more from the 2023 joint ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) annual meeting. What if we could identify MS before anyone experienced any of the typical clinical symptoms? Would treating that person with a high-efficacy disease-modifying therapy prevent the clinical symptoms of MS from even developing? Those are the questions that make the study of the MS prodrome so fascinating and important. At the joint ECTRIMS-ACTRIMS meeting, I met up with one of the foremost experts on the prodromal phase of MS, Dr. Helen Tremlett, who shared an update on what she's continuing to learn about the MS prodrome. We'll also tell you about Dr. Jeffrey Huang's work in developing an experimental drug that may stop MS progression and stimulate remyelination. We're sharing a report from Deloitte that analyzes the economic impact of the pandemic gap for people living with MS in Canada. We'll tell you about the results of a study that show lower-efficacy disease-modifying therapies can lead to faster disability accumulation. You'll hear about the work being done to deliver Ocrevus in a subcutaneous injection. And we'll tell you what happened that caused a study focused on stopping your DMT if your MS was stable to be called off. I had the good fortune of speaking with several research presenters at the joint ECTRIMS-ACTRIMS meeting, and I'll be releasing those bonus ECTRIMS Extra Conversations all week long. It's an opportunity for you to listen in to my conversations with some of the top MS research and clinical experts in the world. Be sure to look for these conversations throughout this week! We have a lot to talk about! Are you ready for RealTalk MS??! This Week: More from the largest MS research conference in the world  :22 Don't miss ECTRIMS Extra Conversations all week long!   Georgetown University researchers develop a drug that may stop MS progression and stimulate remyelination  1:20 The cost of the pandemic gap for people living with MS in Canada   3:10 Study shows that lower-efficacy DMTs can lead to faster disability accumulation  7:12 Clinical trial demonstrates that subcutaneous formulation of Ocrevus is safe and effective  10:47 Your MS stable, no relapses for at least 5 years. Can you stop your DMT?  12:33 Dr. Helen Tremlett explains how understanding the MS prodrome can change the future of MS treatment  15:49 Share this episode  21:26 Have you downloaded the free RealTalk MS app?  21:47 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/321 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com REPORT: The Socioeconomic Cost of, and Impact of, COVID-19 on Multiple Sclerosis in Canada https://mscanada.ca/sites/default/files/documents/2023-10/deloitte-covid-19-impact-english.pdf ECTRIMS PRESENTATION: Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis: Results of the Phase 1b Dose-Finding OCARINA 1 Study https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.congrex/abstracts_ectrims2023/148349.pdf ECTRIMS PRESENTATION: Discontinuation of First-Line Disease-Modifying Therapy in Stable MS (DOT-MS): An Early-Terminated Multicenter Randomized Controlled Trial https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.congrex/abstracts_ectrims2023/146784.pdf Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 321 Guest: Dr. Helen Tremlett Privacy Policy

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at MSMilan, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are: Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center. Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA. Tom Fuchs, MD, PhD, a research fellow at the MS Center at Amsterdam University Medical Center. Barry Singer, MD, the director and founder of The MS Center for Innovations in Care. Georgina Arrambide, a clinical neurologist in the MS Center of Catalunya. Want more from the MSMilan, the joint ECTRIMS-ACTRIMS meeting? Click here for all of NeurologyLive®'s coverage of MSMilan 2023. Episode Breakdown: 1:10 – Joi Williams on expanding the use of biomarkers and the next steps in advancing precision medicine for multiple sclerosis treatment. 2:20 – Voskuhl on the increased research efforts to better understand the links between aging, menopause, and women with MS. 4:30 – Fuchs on the challenges of tracking cognitive decline in multiple sclerosis and improving currently available assessments. 7:50 – Singer on the introduction of biosimilars to MS care, the rigorous approval process they undergo, and the potential benefits they bring to the field. 11:45 – Arrambide on an updated consensus approach to the differential diagnosis of suspected multiple sclerosis, and the red flags clinicians should be aware of during this process. This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com. Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

With about 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Jiwon Oh.  Dr. Oh is a neurologist, scientist, and the Medical Director of the Barlo Multiple Sclerosis Program at St. Michael's Hospital in Toronto, Canada. We have a lot to talk about! Are you ready for RealTalk MS??! SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/ectrims2301 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS ECTRIMS EXTRA with Dr. Jiwon Oh Guest: Dr. Jiwon Oh Privacy Policy

Last week, more than 9,000 MS research scientists and clinicians from more than 110 countries traveled to Milan to attend the largest MS research conference in the world, the 2023 joint ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) annual meeting. In keeping with a RealTalk MS tradition, just as the meeting was ending and the thousands of attendees were heading for the exits, I connected with the National MS Society's Chief Advocacy, Services, and Science Officer, Dr. Tim Coetzee, to discuss some of the research that captured his attention during the 3-day meeting. Earlier in the final day of the joint ECTRIMS-ACTRIMS meeting, I connected with Bonnie Higgins, who was in Milan to participate in the ECTRIMS MS Patient Community Day. Bonnie was diagnosed with MS in 1994, and she shared her perspective on this remarkable conference. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: From the largest MS research conference in the world  :22 Bonnie Higgins shares her perspective on ECTRIMS-ACTRIMS 2023  :50 Dr. Tim Coetzee talks about the ECTRIMS presentations that caught his eye   9:11 Share this episode  16:23 Have you downloaded the free RealTalk MS app?  16:42 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/320 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 320 Guest: Bonnie Higgins and Dr. Tim Coetzee Privacy Policy

ECTRIMS Lecturer Dr. Stephen Hauser deep dives into the most relevant insights from day one of MSMilan2023, with host Brett Drummond.

When you're living with MS, managing your pelvic floor health may not be among the first things you think about. But pelvic floor dysfunction, and the problems that arise from it, like bladder and bowel issues, can seriously impact your health, well-being, and quality of life.  Jill Ehrmantraut, a physical therapist and women's health clinical specialist with advanced training in pelvic rehabilitation, joins me to explain what pelvic floor rehab is all about, why it's important, and how you can get started on the path to improving your pelvic floor health. We'll also tell you about the first 10 drugs that will be subject to price negotiations between Medicare and the companies that manufacture these drugs. (And we'll tell you how that's going to benefit tens of thousands of people living with MS) We'll share the details of how you can weigh in on setting future research priorities for studying women's health in MS.  We'll let you know how you can participate in the Patient Community Day at ECTRIMS, the largest MS research conference in the world. If you're in New York and you're ready to laugh for a good cause, we have the details about the upcoming StandUp2MS comedy club benefit at Gotham Comedy Club. And we're sharing U.S. News & World Report's ranking of the best hospitals in the U.S. for neurology and neurosurgery. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Pelvic floor rehab can be a difference-maker in living your best life with MS   :22 CMS announces the first 10 prescription drugs for which Medicare will negotiate prices  1:19 You can help set future research priorities for studying women's health in MS   3:00 The largest MS research conference in the world is hosting a Patient Community Day   4:17 The StandUp2MS comedy club benefit is less than two weeks away!  5:45 U.S. News & World Report has issued its ranking of the top hospitals in the U.S. for neurology and neurosurgery   6:58 Jill Ehrmantraut explains what pelvic floor health and why it's especially important when you're living with MS   9:52 Share this episode  22:37 Have you downloaded the free RealTalk MS app?  22:57 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/314 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com SURVEY: Research Priorities in Women's Health in Multiple Sclerosis https://ais.swmed.edu/redcap/surveys/?s=8XJPD3PLCJ483KRL MSMilan Patient Community Day Information and Registration https://ectrims.edu/msmilan2023-msmilan-patient-community-day/ Standup2MS Comedy Club Benefit https://standup2ms.org/comedy-club-benefit Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 314 Guest: Jill Ehrmantraut Privacy Policy

Some of you might remember that at the end of October, I was in Amsterdam, attending the 2022 ECTRIMS Congress. ECTRIMS is an acronym for the European Committee for Treatment and Research in Multiple Sclerosis, and their annual scientific congress is the largest MS research conference in the world. As the conference ended, I sat on some steps outside the conference center alongside the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo. And Dr. Bebo shared his initial impressions of some of the research that had been presented over the 3-day conference.  If you missed that episode of the podcast, you may want to listen to episode number 270 of RealTalk MS After having had a few weeks to consider all of the research that was presented at the ECTRIMS Congress, Dr. Bebo is back to share his final ECTRIMS research update, and talk about the rest of the research that caught his attention at the 2022 ECTRIMS Congress. You'll also meet the Co-Chair of the MS Society Southern California chapter's Emerging Leaders Board and this year's recipient of the Dorothy Corwin Spirit of Life Award, Kristen Karasek. Kristen was diagnosed with MS at the age of 24, but, as will become clear to you, she hasn't let MS get in her way. I think you'll find Kristen's positivity to be infectious. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Part Two of our 2022 ECTRIMS research roundup with Dr. Bruce Bebo  :22 My conversation with the Co-Chair of the MS Society Southern California Chapter's Emerging Leaders Board and Dorothy Corwin Spirit of Life recipient, Kristen Karasek  1:37 The National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, discusses the research that caught his attention at the largest MS research conference in the world  16:20 Share this episode  35:21 Download the free RealTalk MS app  35:41 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/276 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS Episode 270: From the 2022 ECTRIMS Congress with Dr. Bruce Bebo https://realtalkms.com/270 Take the iConquer MS Caregiver Survey https://realtalkms.com/caregiver Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 276 Guests: Dr. Bruce Bebo, Kristen Karasek Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with a number of experts in the clinical care of MS who were in attendance at the 2022 ECTRIMS Congress, including Darin T. Okuda, MD, FAAN, FANA, director of Neuroinnovation and Multiple Sclerosis & Neuroimmunology Imaging Program at UT Southwestern Medical Center; Federica Picariello, PhD, a health psychologist and postgraduate research associate at King's College London; Brenda Banwell, MD, chief of the Division of Neurology and codirector of the Neuroscience Center at the Children's Hospital of Philadelphia; Riley Bove, MD, associate professor of neurology, University of California, San Francisco; Tomas Kalincik, MD, PhD, Dame Kate Campbell Professorial Fellow, head of the Clinical Outcomes Research Unit at the University of Melbourne, and head of the MS Centre at the Royal Melbourne Hospital; and Marisa McGinley, DO, a neurologist at the Mellen Center for MS at Cleveland Clinic. Click here for more coverage of ECTRIMS 2022. Episode Breakdown: 1:15 – Darin Okuda, MD, on the implications of the ARISE data in RIS 5:50 – Federica Picariello, PhD, on addressing fatigue and its mechanisms 10:40 – Brenda Banwell, MD, on advances in pediatric-onset MS 16:05 – Riley Bove, MD, on treatment NMOSD in pregnancy and post partum 21:30 – Tomas Kalincik, MD, PhD, on stem cell transplantation in MS 27:00 – Marisa McGinley, DO, on the optimal experience of teleneurology This episode is brought to you by the Medical World News streaming service. Check out new content and shows every day, only at medicalworldnews.com Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Last week, over 7,000 MS researchers and clinicians from more than 100 countries traveled to Amsterdam to attend the 2022 ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) Congress, the largest MS research conference in the world. As has become an annual ECTRIMS tradition on RealTalk MS, the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, and I took up our vantage point on the steps right outside of the convention center to discuss the research that captured Dr. Bebo's attention. We have a lot to talk about! Are you ready for RealTalk MS??! Greetings from the 2022 ECTRIMS Congress!  :22 If you're listening in the U.S., don't forget to vote next Tuesday  1:26 Dr. Bruce Bebo shares the research that captured his attention at ECTRIMS 3:25 Share this episode  20:43 Download the RealTalk MS app for your iOS or Android device   21:03 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/270 ADD YOUR VOICE TO THE CONVERSATION I've always thought of the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Take the iConquer MS Caregiver Survey https://realtalkms.com/caregiver National MS Society: Your Right to Vote and Polling Place Accessibility https://nationalmssociety.org/Get-Involved/Advocate-for-Change/Take-Action/Voter-Info Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 270 Guest: Dr. Bruce Bebo Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy

A couple of months ago, the Inflation Reduction Act was signed into law. And while it touches on many different areas, it will be remembered as the most consequential healthcare bill since the Affordable Care Act. From the emails I've received, I know that many of you are wondering how and when this new law will impact what you pay for your prescription medications. The National MS Society's Vice-President of Advocacy, Steffany Stern, and MS activist Judy Wilson, join me in this episode to explain how this new law benefits people who are living with MS, who, among everyone living with MS, will see some of those benefits first, and when you will begin to see those benefits. We're also talking about a study that showed people with progressive MS are four times more likely to experience serious infection requiring hospitalization, compared to people with relapsing-remitting MS. We'll tell you about a machine-learning algorithm that can predict MS patient outcomes when it comes to symptoms like fatigue, depression, and sleep disturbance. And we'll share some very sobering survey results from the MS Society in the U.K. We have a lot to talk about! Are you ready for RealTalk MS??! Greetings from Amsterdam! ECTRIMS kicks off this week!  :22 This Week: How the Inflation Reduction Act Will Help You  1:02 People with primary progressive MS are 4 times more likely to experience serious infection  2:12 An app plus artificial intelligence predicts MS patient outcomes   5:03 The MS Society in the U.K. releases sobering survey results  9:33 MS Society V.P. of Advocacy Steffany Stern and MS activist Judy Wilson break down the specific benefits of the Inflation Reduction Act   12:17 Share this episode  33:36 Download the RealTalk MS app for your iOS or Android device   33:56 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/269 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Take the iConquer MS Caregiver Survey https://realtalkms.com/caregiver National MS Society: Become an MS Activist https://nationalmssociety.org/advocacy STUDY: Serious Infection in Patients with Relapsing and Progressive Forms of Multiple Sclerosis: A German Claims Data Study https://msard-journal.com/article/S2211-0348(22)00749-0/fulltext STUDY: Predicting Multiple Sclerosis Outcomes During COVID-19 Stay-at-Home Period: Observational Using Passively Sensed Behaviors and Digital Phenotyping https://mental.jmir.org/2022/8/e38495 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 269 Guest: Steffany Stern and Judy Wilson Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy